Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy.
about
Development of cell-penetrating bispecific antibodies targeting the N-terminal domain of androgen receptor for prostate cancer therapy.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Development of cell-penetratin ...... r for prostate cancer therapy.
@en
Development of cell-penetratin ...... r for prostate cancer therapy.
@nl
type
label
Development of cell-penetratin ...... r for prostate cancer therapy.
@en
Development of cell-penetratin ...... r for prostate cancer therapy.
@nl
prefLabel
Development of cell-penetratin ...... r for prostate cancer therapy.
@en
Development of cell-penetratin ...... r for prostate cancer therapy.
@nl
P2093
P2860
P356
P1476
Development of cell-penetratin ...... or for prostate cancer therapy
@en
P2093
Grace Chan
Mary G Blanton
Michael B Lilly
Nancy L Goicochea
Richard Weisbart
P2860
P304
P356
10.1093/PROTEIN/GZX058
P577
2017-12-01T00:00:00Z